Kathrin M. Bernt

5.9k total citations · 1 hit paper
58 papers, 2.4k citations indexed

About

Kathrin M. Bernt is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Kathrin M. Bernt has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 31 papers in Hematology and 12 papers in Oncology. Recurrent topics in Kathrin M. Bernt's work include Acute Myeloid Leukemia Research (28 papers), Epigenetics and DNA Methylation (23 papers) and Protein Degradation and Inhibitors (12 papers). Kathrin M. Bernt is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Epigenetics and DNA Methylation (23 papers) and Protein Degradation and Inhibitors (12 papers). Kathrin M. Bernt collaborates with scholars based in United States, Germany and China. Kathrin M. Bernt's co-authors include Scott A. Armstrong, Amanda Winters, André Lieber, Amit Sinha, Shaoheng Ni, Nan Zhu, Stephen P. Hunger, Eric S. Lander, B. Ogan Mancarci and Patrick Cahan and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Kathrin M. Bernt

55 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chromatin-modifying enzymes as modulators of reprogramming

2012 488 citations Amit Sinha, Nan Zhu et al. profile →

Peers

Kathrin M. Bernt

HEMAT

GENET

ONCOL

PHEOH

Stefan Glaser Australia

Robert K. Slany Germany

Matty Verlaan–de Vries Netherlands

Sonia Minuzzo Italy

Amanda P. Cline United States

Bert Dontje Netherlands

Joachim Schwäble Germany

M Pettersson Sweden

F Birg France

Carolyn A. de Graaf Australia

Stefan Glaser Australia

Kathrin M. Bernt

1.9k ×1.1

465 ×0.7

HEMAT

254 ×0.5

GENET

472 ×1.0

ONCOL

187 ×0.6

PHEOH

Citations per year, relative to Kathrin M. Bernt Kathrin M. Bernt (= 1×) peers Stefan Glaser

Countries citing papers authored by Kathrin M. Bernt

Since Specialization

Citations

This map shows the geographic impact of Kathrin M. Bernt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin M. Bernt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin M. Bernt more than expected).

Fields of papers citing papers by Kathrin M. Bernt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin M. Bernt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin M. Bernt. The network helps show where Kathrin M. Bernt may publish in the future.

Co-authorship network of co-authors of Kathrin M. Bernt

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin M. Bernt. A scholar is included among the top collaborators of Kathrin M. Bernt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin M. Bernt. Kathrin M. Bernt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alikarami‬, Fatemeh, Simone S. Riedel, Sarah K. Tasian, et al.. (2025). Upfront menin-inhibitor resistance in multiply pretreated leukemias. Experimental Hematology. 153. 105268–105268. 1 indexed citations

Wertheim, Gerald, Shikha Gaur, Joseph P. Loftus, et al.. (2025). DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition. Leukemia. 39(5). 1078–1089. 1 indexed citations

Tichy, Elisia D., Zhengfeng Liu, Feikun Yang, et al.. (2025). Single-nucleus multiomic analysis of Beckwith-Wiedemann syndrome liver reveals PPARA signaling enrichment and metabolic dysfunction. Communications Biology. 8(1). 495–495. 1 indexed citations

Riedel, Simone S., Hongbo Xie, Gerald Wertheim, et al.. (2024). FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia. Leukemia. 38(2). 291–301. 11 indexed citations

Bernt, Kathrin M.. (2024). Mapping human hematopoiesis. Nature Immunology. 25(4). 590–591. 1 indexed citations

Xie, Hongbo, Fatemeh Alikarami‬, Simone S. Riedel, et al.. (2023). Transcriptomic without Clinical Response to Menin Inhibition As a Mechanism of Upfront Resistance in Samples from Mutliply Relapsed Patients with KMT2A-Rearranged Leukemia. Blood. 142(Supplement 1). 4166–4166.

Xie, Hongbo & Kathrin M. Bernt. (2022). HOXA Amplification Defines a Genetically Distinct Subset of Angiosarcomas. Biomolecules. 12(8). 1124–1124. 9 indexed citations

Huang, Hua, Qingzhou Chen, Fatemeh Alikarami‬, et al.. (2022). Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia. iScience. 25(10). 105139–105139. 3 indexed citations

Xie, Hongbo, Simone S. Riedel, Zuo‐Fei Yuan, et al.. (2020). Epigenetic regulation of protein translation in KMT2A-rearranged AML. Experimental Hematology. 85. 57–69. 8 indexed citations

10.

Xie, Hongbo, Simone S. Riedel, Sally P. Stabler, et al.. (2020). Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML. Blood Advances. 4(13). 3109–3122. 4 indexed citations

11.

Liu, Haolin, Ryan C. Hill, Chunjing Chen, et al.. (2020). JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes. eLife. 9. 22 indexed citations

12.

Singh, Vijender, Kathrin M. Bernt, David W. Rowe, et al.. (2020). Mesenchyme-specific loss of Dot1L histone methyltransferase leads to skeletal dysplasia phenotype in mice. Bone. 142. 115677–115677. 9 indexed citations

13.

Campbell, Carly, David A. Drubin, Timothy M. Thomson, et al.. (2017). Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in MLL -Rearranged Leukemia. Molecular Cancer Therapeutics. 16(8). 1669–1679. 46 indexed citations

14.

Bernt, Kathrin M., Stephen P. Hunger, & Tobias Neff. (2016). The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities. Frontiers in Pediatrics. 4. 49–49. 9 indexed citations

15.

Riedel, Simone S., et al.. (2016). Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy. Experimental Hematology. 44(7). 596–602.e3. 8 indexed citations

16.

Chen, Chun‐Wei, Richard P. Koche, Amit Sinha, et al.. (2015). DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nature Medicine. 21(4). 335–343. 155 indexed citations

17.

Deshpande, Aniruddha J., Anagha Deshpande, Amit Sinha, et al.. (2014). AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes. Cancer Cell. 26(6). 896–908. 132 indexed citations

18.

Bernt, Kathrin M. & Scott A. Armstrong. (2008). Leukemia Stem Cells and Human Acute Lymphoblastic Leukemia. Seminars in Hematology. 46(1). 33–38. 33 indexed citations

19.

Bernt, Kathrin M., et al.. (2005). Assessment of a Combined, Adenovirus-Mediated Oncolytic and Immunostimulatory Tumor Therapy. Cancer Research. 65(10). 4343–4352. 43 indexed citations

20.

Bernt, Kathrin M., Shaoheng Ni, Zong-Yi Li, Dmitry M. Shayakhmetov, & André Lieber. (2003). The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors. Molecular Therapy. 8(5). 746–755. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact